美股詳情

本頁面由Tiger Fintech (Singapore) Pte. Ltd.提供服務

亞盛醫藥

40.40

-0.6400-1.56%

盤後：40.490.0900+0.22%16:10 EDT

成交量：3,944.00

成交額：16.02萬

市值：37.64億

市盈率：-54.92

高：40.98

開：40.98

低：40.34

收：41.04

52周最高：48.45

52周最低：16.50

股本：9,316.78萬

流通股本：7,158.28萬

量比：0.28

換手率：0.01%

股息：- -

股息率：- -

每股收益(TTM):-0.7356

每股收益(LYR):-0.7356

淨資產收益率：-159.65%

總資產收益率：-22.77%

市淨率：40.26

市盈率(LYR):-54.92

資料載入中...

總覽公司新聞公告

亞盛醫藥5月5日成交額為33.42萬美元

亞盛醫藥5月2日成交額為40.30萬美元

亞盛醫藥4月30日成交額為51.34萬美元

亞盛醫藥4月28日成交額為14.73萬美元

【直擊AACR 2025】亞盛醫藥公佈五項臨牀前進展，耐立克®聯合APG-2575展現顯著協同效應

亞盛醫藥-B(06855)五項臨牀前進展亮相2025年AACR年會，耐立克®聯合APG-2575展現顯著協同效應

一週港股牛熊榜 | 醫藥股表現喜人，亞盛醫藥升38%，榮昌生物升逾30%；京東集團本週跌11%

亞盛醫藥4月24日成交額為163.21萬美元

亞盛醫藥兩項研究入選2025年ASCO年會

亞盛醫藥-B(06855)兩項研究入選2025年美國臨牀腫瘤學會年會包括一個Lisaftoclax (APG-2575)口頭報告

亞盛醫藥4月22日成交額為258.18萬美元

2025 CSCO指南更新：亞盛醫藥-B(06855)APG-2575首獲推薦耐立克®獲升級推薦

亞盛醫藥4月17日成交額為5.86萬美元

亞盛醫藥4月15日成交額為178.96萬美元

亞盛醫藥上漲11.66%，報20.88美元/股，總市值18.18億美元

亞盛醫藥上漲7.29%，報18.991美元/股，總市值16.54億美元

亞盛醫藥4月10日成交額為26.80萬美元

亞盛醫藥4月9日成交額為56.90萬美元

亞盛醫藥受託人購入5萬股總價176萬港元

亞盛醫藥4月8日成交額為367.13萬美元

{"basename":"/hant","ssrTDKData":{"titleTemplate":"%s - 老虎證券","title":"老虎证券全球投资理财平台| 一站式投资美股新股港股A股","description":"老虎证券助您一站式投资美股，新股，港股，A股等全球金融理财产品。新加坡华人最信赖的在线投资平台，现在加入即享低费用，24/5 无时差炒美股投资理财！","keywords":"老虎證券,老虎證券開戶,老虎券商,老虎證券官網,老虎證券app,tigertrade老虎證券,股票,炒股,新加坡股票交易平臺,投資,投資理財","social":{"ogDescription":"老虎证券助您一站式投资美股，新股，港股，A股等全球金融理财产品。新加坡华人最信赖的在线投资平台，现在加入即享低费用，24/5 无时差炒美股投资理财！","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.be62fbe1.png","ogUrl":"https://www.itiger.com/hant/stock/AAPG/news?page=7"},"companyName":"老虎證券"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"SGP","license":"TBSG","edition":"fundamental","symbol":"AAPG","isAnalysisPage":false},"__swrFallback__":{"@#url:\"https://hq.skytigris.cn/stock_info/detail/global\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"AAPG\",,,,,undefined,":{"symbol":"AAPG","market":"US","secType":"STK","nameCN":"亞盛醫藥","latestPrice":40.4,"timestamp":1757448000000,"preClose":41.04,"halted":0,"volume":3944,"hourTrading":{"tag":"盘后","latestPrice":40.49,"preClose":40.4,"latestTime":"16:10 EDT","volume":42,"amount":1697.2799340000001,"timestamp":1757448603723},"delay":0,"floatShares":71582800,"shares":93167803,"eps":-0.735552,"marketStatus":"盤後交易","change":-0.64,"latestTime":"09-09 17:41:43 EDT","open":40.98,"high":40.98,"low":40.3391,"amount":160198.261,"amplitude":0.015616,"askPrice":40.85,"askSize":126,"bidPrice":35.67,"bidSize":100,"shortable":3,"etf":0,"ttmEps":-0.735552,"tradingStatus":3,"nextMarketStatus":{"tag":"收盤","tradingStatus":0,"beginTime":1757462400000},"marketStatusCode":4,"adr":0,"adrRate":4,"listingDate":1737694800000,"exchange":"NASDAQ","adjPreClose":41.04,"postHourTrading":{"tag":"盘后","latestPrice":40.49,"preClose":40.4,"latestTime":"16:10 EDT","volume":42,"amount":1697.2799340000001,"timestamp":1757448603723},"volumeRatio":0.276959},"@#url:\"https://hq.skytigris.cn/stock_info/fundamental/all\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"AAPG\",,,,,undefined,":{"symbol":"AAPG","floatShares":71582800,"roa":"-22.77%","roe":"-159.65%","lyrEps":-0.735552,"volumeRatio":0.276959,"shares":93167803,"dividePrice":0,"high":40.98,"amplitude":0.015616,"preClose":41.04,"low":40.3391,"week52Low":16.5,"pbRate":"40.26","psRate":"68.65","week52High":48.45,"institutionHeld":0,"latestPrice":40.4,"committee":-0.115044,"eps":-0.735552,"divideRate":0,"volume":3944,"delay":0,"ttmEps":-0.735552,"open":40.98,"prevYearClose":17.25,"prevWeekClose":40.4987,"prevMonthClose":42.47,"prevQuarterClose":39.375,"fiveDayClose":41.82,"twentyDayClose":40.04,"sixtyDayClose":32.02},"@#url:\"https://hq.skytigris.cn/fundamental/corporate_actions/details/AAPG\",params:#limit:5,,,undefined,":[{"market":"US","date":"2025-08-20","symbol":"AAPG","fiscalQuarterEnding":"2025/06","expectedEps":null,"name":null,"time":"盤後","type":"earning","dateTimestamp":1755662400000,"reportTimeType":"post","actualEps":null},{"date":"2025-03-27","symbol":"AAPG","type":"earning","reportTimeType":"pre","market":"US","fiscalQuarterEnding":"2024/12","expectedEps":null,"defaultRemindTime":1743062400000,"name":null,"time":"盤前","dateTimestamp":1743048000000,"actualEps":null}],"@#url:\"https://hq.skytigris.cn/fundamental/dividend/history\",params:#symbol:\"AAPG\",market:\"US\",,,undefined,":[],"@#url:\"https://hq.skytigris.cn/fundamental/estimate/recommendation\",params:#symbol:\"AAPG\",market:\"US\",delay:false,,,undefined,":{"strongBuy":0,"buy":1,"hold":0,"sell":0,"strongSell":0,"meanLabel":"BUY","meanPercent":1,"analysts":2,"updateTime":1743652800000},"@#url:\"https://hq.skytigris.cn/value_analysis/stock/AAPG\",params:#withQuantilePoint:true,period:\"5year\",factor:\"peRate\",delay:false,algorithm:1,,,undefined,":{"brief":{"id":"AAPG","date":"2025-09-08","current":-23.478386,"percent":0.980392,"low":-76.454813,"twenty":-59.602544,"median":-36.307775,"eighty":-31.810921,"high":-21.702816,"avg":-42.462654,"sd":14.204425,"marketCap":3817512539.24},"quantilePoints":[{"date":"2025-01-31","current":-29.751262,"twenty":-29.75286,"median":-29.751983,"eighty":-29.751262,"marketCap":1478269659.08},{"date":"2025-02-07","current":-32.664532,"twenty":-32.365221,"median":-31.242401,"eighty":-29.752127,"marketCap":1614694688.16},{"date":"2025-02-14","current":-31.1828,"twenty":-32.258438,"median":-31.212601,"eighty":-29.752938,"marketCap":1540476496.81},{"date":"2025-02-21","current":-36.382297,"twenty":-32.721933,"median":-31.802125,"eighty":-29.819279,"marketCap":1806628873.73},{"date":"2025-02-28","current":-33.43308,"twenty":-34.468465,"median":-32.375664,"eighty":-30.230932,"marketCap":1654638501.56},{"date":"2025-03-07","current":-34.452224,"twenty":-34.328072,"median":-32.712367,"eighty":-30.892818,"marketCap":1712841480.27},{"date":"2025-03-14","current":-33.065652,"twenty":-34.096417,"median":-32.760201,"eighty":-31.20664,"marketCap":1644428002.08},{"date":"2025-03-21","current":-32.72391,"twenty":-34.124503,"median":-32.947597,"eighty":-31.448698,"marketCap":1626713850.02},{"date":"2025-03-28","current":-33.955809,"twenty":-34.124503,"median":-33.010704,"eighty":-31.793328,"marketCap":1894714451.86},{"date":"2025-04-04","current":-35.921968,"twenty":-34.855052,"median":-33.21342,"eighty":-31.979778,"marketCap":2000185586.04},{"date":"2025-04-11","current":-29.511221,"twenty":-34.370118,"median":-33.010704,"eighty":-30.892818,"marketCap":1635879540.94},{"date":"2025-04-17","current":-29.520055,"twenty":-34.225935,"median":-32.760201,"eighty":-30.07059,"marketCap":1639709582.7},{"date":"2025-04-25","current":-41.553435,"twenty":-35.045268,"median":-32.920123,"eighty":-30.119556,"marketCap":2311372741.24},{"date":"2025-05-02","current":-38.492689,"twenty":-35.554336,"median":-33.187028,"eighty":-30.682879,"marketCap":2146245101.28},{"date":"2025-05-09","current":-37.35919,"twenty":-36.170996,"median":-33.361942,"eighty":-30.776099,"marketCap":2093177176.92},{"date":"2025-05-16","current":-35.007117,"twenty":-35.955639,"median":-33.43308,"eighty":-31.102567,"marketCap":1969122395.28},{"date":"2025-05-23","current":-39.338512,"twenty":-36.352488,"median":-33.608398,"eighty":-31.19472,"marketCap":2213435510.22},{"date":"2025-05-30","current":-38.856398,"twenty":-37.35919,"median":-33.992043,"eighty":-31.242401,"marketCap":2192363417.29},{"date":"2025-06-06","current":-42.814884,"twenty":-37.865895,"median":-34.141844,"eighty":-31.758144,"marketCap":2419987007.19},{"date":"2025-06-13","current":-48.171029,"twenty":-38.492689,"median":-34.477812,"eighty":-31.846105,"marketCap":2722575737.57},{"date":"2025-06-20","current":-55.929302,"twenty":-38.862859,"median":-34.635358,"eighty":-32.113451,"marketCap":3154688383.5},{"date":"2025-06-27","current":-59.787237,"twenty":-39.399619,"median":-35.123604,"eighty":-32.336589,"marketCap":3381751544.24},{"date":"2025-07-03","current":-64.068526,"twenty":-41.436089,"median":-35.258863,"eighty":-32.429915,"marketCap":3624015684.35},{"date":"2025-07-11","current":-59.084566,"twenty":-43.897892,"median":-35.501693,"eighty":-32.48435,"marketCap":3338745741.38},{"date":"2025-07-18","current":-61.880278,"twenty":-48.308604,"median":-35.791073,"eighty":-32.545465,"marketCap":3494679880.36},{"date":"2025-07-25","current":-58.315576,"twenty":-54.849764,"median":-35.921968,"eighty":-32.616809,"marketCap":3304687864.64},{"date":"2025-08-01","current":-60.559654,"twenty":-57.422661,"median":-36.233253,"eighty":-32.655768,"marketCap":3410643633.03},{"date":"2025-08-08","current":-69.260076,"twenty":-59.023969,"median":-36.597865,"eighty":-32.679287,"marketCap":3910472388.03},{"date":"2025-08-15","current":-72.346957,"twenty":-59.602544,"median":-37.391167,"eighty":-32.709995,"marketCap":4086922647.44},{"date":"2025-08-22","current":-26.724459,"twenty":-60.097702,"median":-37.493155,"eighty":-32.679287,"marketCap":4314209810.62},{"date":"2025-08-29","current":-24.396919,"twenty":-59.865528,"median":-36.699167,"eighty":-32.48435,"marketCap":3966417985.85},{"date":"2025-09-05","current":-22.946281,"twenty":-59.664109,"median":-36.382297,"eighty":-31.979778,"marketCap":3724203040.4},{"date":"2025-09-08","current":-23.478386,"twenty":-59.602544,"median":-36.307775,"eighty":-31.810921,"marketCap":3817512539.24}],"updateTime":1757454103123},"$inf$@#url:\"https://stock-news.skytigris.cn/v2/news/list\",params:#symbols:\"AAPG\",pageSize:20,pageCount:7,lang_content:\"cn\",edition:\"fundamental\",,,undefined,":[{"items":[{"id":"2533911095","title":"亞盛醫藥5月5日成交額為33.42萬美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2533911095","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2533911095?lang=zh_tw&edition=fundamental","pubTime":"2025-05-06 09:15","pubTimestamp":1746494110,"startTime":"0","endTime":"0","summary":"美东时间2025年5月5日，亚盛医药成交额为33.42万美元，成交额较昨日减少17.07%，当日成交量为1.32万股。亚盛医药于2025年5月5日跌0.71%，报25.3美元，该股过去5个交易日涨0.04%，年初至今涨46.67%，过去60日涨34.57%。|近5个交易日成交情况||||#|日期|成交额（美元）|成交额较昨日变化|成交量（股）|#|2025-05-05|33.42万|-17.07%|1.32万|#|2025-05-02|40.30万|156.00%|1.59万|#|2025-05-01|15.74万|-69.34%|6332.00|#|2025-04-30|51.34万|176.53%|2.09万|#|2025-04-29|18.57万|26.02%|7560.00|亚盛医药集团是一家临床阶段的生物技术公司，从事癌症、乙型肝炎病毒和某些年龄相关疾病的创新小分子疗法的开发和销售。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250506091516a4735099&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250506091516a4735099&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["AAPG","BK4139"],"gpt_icon":0},{"id":"2532654801","title":"亞盛醫藥5月2日成交額為40.30萬美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2532654801","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2532654801?lang=zh_tw&edition=fundamental","pubTime":"2025-05-03 09:15","pubTimestamp":1746234911,"startTime":"0","endTime":"0","summary":"美东时间2025年5月2日，亚盛医药成交额为40.30万美元，成交额较昨日增加156.00%，当日成交量为1.59万股。亚盛医药于2025年5月2日涨1.31%，报25.48美元，该股过去5个交易日跌3.12%，年初至今涨47.71%，过去60日涨41.16%。|近5个交易日成交情况||||#|日期|成交额（美元）|成交额较昨日变化|成交量（股）|#|2025-05-02|40.30万|156.00%|1.59万|#|2025-05-01|15.74万|-69.34%|6332.00|#|2025-04-30|51.34万|176.53%|2.09万|#|2025-04-29|18.57万|26.02%|7560.00|#|2025-04-28|14.73万|-86.22%|5810.00|亚盛医药集团是一家临床阶段的生物技术公司，从事癌症、乙型肝炎病毒和某些年龄相关疾病的创新小分子疗法的开发和销售。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250503091519a4707e87&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250503091519a4707e87&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","AAPG"],"gpt_icon":0},{"id":"2532310017","title":"亞盛醫藥4月30日成交額為51.34萬美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2532310017","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2532310017?lang=zh_tw&edition=fundamental","pubTime":"2025-05-01 09:15","pubTimestamp":1746062111,"startTime":"0","endTime":"0","summary":"美东时间2025年4月30日，亚盛医药成交额为51.34万美元，成交额较昨日增加176.53%，当日成交量为2.09万股。亚盛医药于2025年4月30日涨0.95%，报24.43美元，该股过去5个交易日涨2.22%，年初至今涨41.62%，过去60日涨34.23%。该公司的地理部门包括美国和中国大陆。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250501091517a6cf8335&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250501091517a6cf8335&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","AAPG"],"gpt_icon":0},{"id":"2531213584","title":"亞盛醫藥4月28日成交額為14.73萬美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2531213584","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2531213584?lang=zh_tw&edition=fundamental","pubTime":"2025-04-29 09:15","pubTimestamp":1745889311,"startTime":"0","endTime":"0","summary":"美东时间2025年4月28日，亚盛医药成交额为14.73万美元，成交额较昨日减少86.22%，当日成交量为5810.00股。亚盛医药于2025年4月28日跌3.82%，报25.29美元，该股过去5个交易日涨32.27%，年初至今涨46.61%，过去60日涨43.69%。该公司的地理部门包括美国和中国大陆。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250429091517a6cc6c54&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250429091517a6cc6c54&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["AAPG","BK4139"],"gpt_icon":0},{"id":"2531268664","title":"【直擊AACR 2025】亞盛醫藥公佈五項臨牀前進展，耐立克®聯合APG-2575展現顯著協同效應","url":"https://stock-news.laohu8.com/highlight/detail?id=2531268664","media":"美通社","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2531268664?lang=zh_tw&edition=fundamental","pubTime":"2025-04-28 23:13","pubTimestamp":1745853180,"startTime":"0","endTime":"0","summary":"特别值得关注的是，公司两个重磅品种奥雷巴替尼与APG-2575联合用药在AML及T-ALL模型中的协同效应，有望为相关治疗领域带来新的治疗方案。总结：   在维奈克拉耐药AML细胞系中，奥雷巴替尼联合APG-2575协同抑制了细胞增殖并诱导了细胞凋亡。新型Bcl-2抑制剂APG-2575目前正在针对多种血液恶性肿瘤的开展多项后期临床试验。该联合方案在MOLT4异种移植模型中同样表现出显著的协同抑瘤效应。APG-5918与恩扎卢胺联合用药表现出协同抑制细胞增殖的效应。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://wwwold.prnasia.com/story/archive/4674082_ZH74082_1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"prnasia","symbols":["LU1923622291.USD","APG","LU2125909916.SGD","BK1161","BK4139","LU2125909759.SGD","BK4129","BK1574","AAPG","06855"],"gpt_icon":0},{"id":"2530387403","title":"亞盛醫藥-B(06855)五項臨牀前進展亮相2025年AACR年會，耐立克®聯合APG-2575展現顯著協同效應","url":"https://stock-news.laohu8.com/highlight/detail?id=2530387403","media":"智通财经","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2530387403?lang=zh_tw&edition=fundamental","pubTime":"2025-04-28 19:49","pubTimestamp":1745840941,"startTime":"0","endTime":"0","summary":"智通财经APP讯，亚盛医药-B 发布公告，公司于2025年4月25日至2025年4月30日在美国芝加哥举行的2025年美国癌症研究协会年会上，以壁报形式公布了五项临床前研究成果。本次壁报涉及公司五个品种，包括：原创1类新药奥雷巴替尼、Bcl-2抑制剂APG-2575、FAK/ALK/ROS1三联酪氨酸激酶抑制剂APG-2449、胚胎外胚层发育蛋白抑制剂APG-5918以及IAP拮抗剂AS03157。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1286639.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["BK4129","BK4139","BK1574","AAPG","LU2125909916.SGD","BK1161","LU1923622291.USD","06855","LU2125909759.SGD","APG"],"gpt_icon":0},{"id":"1100184519","title":"一週港股牛熊榜 | 醫藥股表現喜人，亞盛醫藥升38%，榮昌生物升逾30%；京東集團本週跌11%","url":"https://stock-news.laohu8.com/highlight/detail?id=1100184519","media":"老虎資訊","labels":["movement"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1100184519?lang=zh_tw&edition=fundamental","pubTime":"2025-04-25 17:48","pubTimestamp":1745574485,"startTime":"0","endTime":"0","summary":"$荣昌生物$ 本周升逾30%，根據香港聯交所4月23日披露的文件，Allianz SE於4月16日以每股均價33.9181港元增持榮昌生物257.55萬股H股股份，價值約8,735.61萬港元。增持後，Allianz SE最新持股數目爲1,106.05萬股股份，好倉比例由4.48%升至5.83%。","market":"hk","thumbnail":"https://community-static.tradeup.com/news/6b12b30d7cf0af9a2b6d2683230cd48c","type":0,"news_type":0,"thumbnails":["https://community-static.tradeup.com/news/6b12b30d7cf0af9a2b6d2683230cd48c"],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":true,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"movement","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4505","LU2148510915.USD","BK4504","BK0239","09939","09618","AAPG","BK4551","BK1161","YANG","159938","688331","09995","LU1880383366.USD","BK4122","07226","LU0106959298.USD","HSTECH","HSCEI"],"gpt_icon":1},{"id":"2530914089","title":"亞盛醫藥4月24日成交額為163.21萬美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2530914089","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2530914089?lang=zh_tw&edition=fundamental","pubTime":"2025-04-25 09:15","pubTimestamp":1745543709,"startTime":"0","endTime":"0","summary":"美东时间2025年4月24日，亚盛医药成交额为163.21万美元，成交额较昨日增加28.83%，当日成交量为6.38万股。亚盛医药于2025年4月24日涨6.69%，报25.5美元，该股过去5个交易日涨35.14%，年初至今涨47.83%，过去60日涨48.26%。它专注于开发抑制蛋白质间相互作用以恢复细胞凋亡或程序性细胞死亡的疗法。该公司的地理部门包括美国和中国大陆。（以上内容为腾讯自选股基于公开消息，由程序或算法智能生成，仅作为用户看盘参考，不作为投资建议或交易依据。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250425091522a6c754c1&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250425091522a6c754c1&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","AAPG"],"gpt_icon":0},{"id":"2529623787","title":"亞盛醫藥兩項研究入選2025年ASCO年會","url":"https://stock-news.laohu8.com/highlight/detail?id=2529623787","media":"财中社","labels":["conferences"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2529623787?lang=zh_tw&edition=fundamental","pubTime":"2025-04-24 15:06","pubTimestamp":1745478416,"startTime":"0","endTime":"0","summary":"4月24日，亚盛医药-B（06855）发布公告，宣布其两项研究成果入选2025年美国临床肿瘤学会（ASCO）年会。细胞凋亡管线重点品种Bcl-2选择性抑制剂Lisaftoclax（APG-2575）联合治疗髓系恶性肿瘤患者的Ib/II期研究最新进展将以口头报告的形式展示。该研究的摘要编号为6505，报告时间定于2025年6月2日下午15:00至18:00（美国中部时间）。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://finance.eastmoney.com/a/202504243387193830.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"conferences","news_rank":0,"length":0,"strategy_id":0,"source":"stock_eastmoney","symbols":["BK4139","AAPG"],"gpt_icon":0},{"id":"2529269844","title":"亞盛醫藥-B(06855)兩項研究入選2025年美國臨牀腫瘤學會年會 包括一個Lisaftoclax (APG-2575)口頭報告","url":"https://stock-news.laohu8.com/highlight/detail?id=2529269844","media":"智通财经","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2529269844?lang=zh_tw&edition=fundamental","pubTime":"2025-04-24 07:13","pubTimestamp":1745450023,"startTime":"0","endTime":"0","summary":"智通财经APP讯，亚盛医药-B 发布公告，公司细胞凋亡管线重点品种Bcl-2选择性抑制剂Lisaftoclax和MDM2-p53抑制剂Alrizomadlin 的两项临床研究成果入选2025年美国临床肿瘤学会年会，其中，APG-2575联合治疗髓系恶性肿瘤患者的Ib/II期研究最新进展获口头报告。本届ASCO年会将于2025年5月30日至2025年6月3日在芝加哥McCormick会议中心以线上线下结合的形式举办。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1283681.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["BK1574","AAPG","BK4129","LU2125909916.SGD","06855","BK4139","BK1161","LU1923622291.USD","LU2125909759.SGD","APG"],"gpt_icon":0},{"id":"2529759479","title":"亞盛醫藥4月22日成交額為258.18萬美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2529759479","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2529759479?lang=zh_tw&edition=fundamental","pubTime":"2025-04-23 09:15","pubTimestamp":1745370910,"startTime":"0","endTime":"0","summary":"美东时间2025年4月22日，亚盛医药成交额为258.18万美元，成交额较昨日增加1131.94%，当日成交量为12.01万股。亚盛医药于2025年4月22日涨12.97%，报21.6美元，该股过去5个交易日涨5.42%，年初至今涨25.22%，过去60日涨24.28%。|近5个交易日成交情况||||#|日期|成交额（美元）|成交额较昨日变化|成交量（股）|#|2025-04-22|258.18万|1131.94%|12.01万|#|2025-04-21|20.96万|257.69%|1.10万|#|2025-04-17|5.86万|397.59%|3120.00|#|2025-04-16|1.18万|-99.34%|624.00|#|2025-04-15|178.96万|430.92%|9.15万|亚盛医药集团是一家临床阶段的生物技术公司，从事癌症、乙型肝炎病毒和某些年龄相关疾病的创新小分子疗法的开发和销售。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250423091517a6c47820&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250423091517a6c47820&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","AAPG"],"gpt_icon":0},{"id":"2529877876","title":"2025 CSCO指南更新：亞盛醫藥-B(06855)APG-2575首獲推薦 耐立克®獲升級推薦","url":"https://stock-news.laohu8.com/highlight/detail?id=2529877876","media":"智通财经","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2529877876?lang=zh_tw&edition=fundamental","pubTime":"2025-04-21 19:26","pubTimestamp":1745234776,"startTime":"0","endTime":"0","summary":"智通财经APP讯，亚盛医药-B 发布公告，公司自主研发的两款重磅创新药均获纳入2025年中国临床肿瘤学会系列指南：在研品种新型口服 Bcl-2选择性抑制剂Lisaftoclax首次获《CSCO淋巴瘤诊疗指南》推荐。2024年11月，Lisaftoclax单药治疗R/R CLL/SLL的NDA申请已获国家药监局药品审评中心受理并纳入优先审评。此次2025版《 CSCO儿童及青少年白血病诊疗指南》在针对费城染色体阳性急性淋巴细胞白血病儿童患者的治疗中，首次将奥雷巴替尼升级为I级推荐治疗方案用于BCR-ABL1激酶区T315I突变患者。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1281643.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["LU2237443622.USD","BK4560","SG9999015986.USD","LU1059921491.USD","LU0889566641.SGD","LU1571399168.USD","IE00BVYPNV92.GBP","LU0203345920.USD","BK4020","LU1880398471.USD","LU1506573853.SGD","BK4533","LU2237443549.SGD","LU2237443978.SGD","BK4527","LU0823417737.USD","BK4550","SG9999015945.SGD","SG9999001440.SGD","LU1244550577.SGD","LU1880398554.USD","BK1574","BK4525","LU1585245621.USD","IE00BSNM7G36.USD","LU0792757196.USD","IE00B3T34201.USD","LU0731783394.SGD","LU2125909916.SGD","LU2237443382.USD","SG9999015952.SGD","IE00BGHQF631.EUR","LU0348723411.USD","LU1430594728.SGD","LU1046421795.USD","LU1066051225.USD","APG","LU0234570918.USD","LU1235294995.USD","BK4534","IE00BFXG1179.USD","06855","LU0234572021.USD","LU1599440770.SGD","BK4579","AAPG","LU2237443895.HKD","IE00BVYPNW00.USD","BK4581","CSCO"],"gpt_icon":0},{"id":"2528660701","title":"亞盛醫藥4月17日成交額為5.86萬美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2528660701","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2528660701?lang=zh_tw&edition=fundamental","pubTime":"2025-04-18 09:15","pubTimestamp":1744938909,"startTime":"0","endTime":"0","summary":"美东时间2025年4月17日，亚盛医药成交额为5.86万美元，成交额较昨日增加397.59%，当日成交量为3120.00股。亚盛医药于2025年4月17日跌0.79%，报18.72美元，该股过去5个交易日涨5.76%，年初至今涨8.52%，过去60日涨8.52%。该公司的地理部门包括美国和中国大陆。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250418091514a45d3b1e&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250418091514a45d3b1e&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["AAPG","BK4139"],"gpt_icon":0},{"id":"2527096094","title":"亞盛醫藥4月15日成交額為178.96萬美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2527096094","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2527096094?lang=zh_tw&edition=fundamental","pubTime":"2025-04-16 09:15","pubTimestamp":1744766109,"startTime":"0","endTime":"0","summary":"美东时间2025年4月15日，亚盛医药成交额为178.96万美元，成交额较昨日增加430.92%，当日成交量为9.15万股。亚盛医药于2025年4月15日跌5.08%，报19.45美元，该股过去5个交易日跌0.05%，年初至今涨12.75%，过去60日涨12.75%。它专注于开发抑制蛋白质间相互作用以恢复细胞凋亡或程序性细胞死亡的疗法。该公司的地理部门包括美国和中国大陆。（以上内容为腾讯自选股基于公开消息，由程序或算法智能生成，仅作为用户看盘参考，不作为投资建议或交易依据。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250416091514a6bbdfde&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250416091514a6bbdfde&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["AAPG","BK4139"],"gpt_icon":0},{"id":"2527146766","title":"亞盛醫藥上漲11.66%，報20.88美元/股，總市值18.18億美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2527146766","media":"金融界","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2527146766?lang=zh_tw&edition=fundamental","pubTime":"2025-04-15 03:58","pubTimestamp":1744660697,"startTime":"0","endTime":"0","summary":"4月15日，亚盛医药盘中上涨11.66%，截至03:58，报20.88美元/股，成交29.43万美元，总市值18.18亿美元。财务数据显示，截至2024年12月31日，亚盛医药收入总额9.81亿人民币，同比增长341.77%；归母净利润-4.05亿人民币，同比增长56.2%。目前公司正在中国、美国、澳大利亚及欧洲开展40多项临床试验。截至目前,公司共有4个在研新药获得16项FDA和1项欧盟孤儿药资格认定,2项FDA快速通道资格以及2项FDA儿童罕见病资格认证。","market":"hk","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://finance.jrj.com.cn/2025/04/15035849536897.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"2","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"jinrongjie_stock","symbols":["AAPG","BK4139"],"gpt_icon":0},{"id":"2526690131","title":"亞盛醫藥上漲7.29%，報18.991美元/股，總市值16.54億美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2526690131","media":"金融界","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2526690131?lang=zh_tw&edition=fundamental","pubTime":"2025-04-12 00:05","pubTimestamp":1744387546,"startTime":"0","endTime":"0","summary":"4月12日，亚盛医药盘中上涨7.29%，截至00:05，报18.991美元/股，成交83.24万美元，总市值16.54亿美元。财务数据显示，截至2024年12月31日，亚盛医药收入总额9.81亿人民币，同比增长341.77%；归母净利润-4.05亿人民币，同比增长56.2%。目前公司正在中国、美国、澳大利亚及欧洲开展40多项临床试验。截至目前,公司共有4个在研新药获得16项FDA和1项欧盟孤儿药资格认定,2项FDA快速通道资格以及2项FDA儿童罕见病资格认证。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://finance.jrj.com.cn/2025/04/12000549505844.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"jinrongjie_stock","symbols":["AAPG","BK4139"],"gpt_icon":0},{"id":"2526157552","title":"亞盛醫藥4月10日成交額為26.80萬美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2526157552","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2526157552?lang=zh_tw&edition=fundamental","pubTime":"2025-04-11 09:15","pubTimestamp":1744334113,"startTime":"0","endTime":"0","summary":"美东时间2025年4月10日，亚盛医药成交额为26.80万美元，成交额较昨日减少52.89%，当日成交量为1.49万股。亚盛医药于2025年4月10日跌6.84%，报17.7美元，该股过去5个交易日跌23.28%，年初至今涨2.61%，过去60日涨2.61%。该公司的地理部门包括美国和中国大陆。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250411091524a45591c3&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250411091524a45591c3&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","AAPG"],"gpt_icon":0},{"id":"2526240953","title":"亞盛醫藥4月9日成交額為56.90萬美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2526240953","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2526240953?lang=zh_tw&edition=fundamental","pubTime":"2025-04-10 09:15","pubTimestamp":1744247712,"startTime":"0","endTime":"0","summary":"美东时间2025年4月9日，亚盛医药成交额为56.90万美元，成交额较昨日减少84.50%，当日成交量为3.09万股。亚盛医药于2025年4月9日跌2.36%，报19.0美元，该股过去5个交易日跌17.39%，年初至今涨10.14%，过去60日涨10.14%。它专注于开发抑制蛋白质间相互作用以恢复细胞凋亡或程序性细胞死亡的疗法。该公司的地理部门包括美国和中国大陆。（以上内容为腾讯自选股基于公开消息，由程序或算法智能生成，仅作为用户看盘参考，不作为投资建议或交易依据。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250410091526a6b5fc4e&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250410091526a6b5fc4e&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["AAPG","BK4139"],"gpt_icon":0},{"id":"2526879852","title":"亞盛醫藥受託人購入5萬股 總價176萬港元","url":"https://stock-news.laohu8.com/highlight/detail?id=2526879852","media":"财中社","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2526879852?lang=zh_tw&edition=fundamental","pubTime":"2025-04-09 09:18","pubTimestamp":1744161496,"startTime":"0","endTime":"0","summary":"亚盛医药（06855）发布公告，受托人于2025年4月8日根据2022年受限制股份单位计划目的，购买了合共5万股现有股份。这些股份占公司在公告日期已发行股份总数的约0.014%。此次购买的总代价为176万港元，平均每股购买价格约为35.2港元。公告中提到，受托人持有的股份总数目前为217万股，均根据2022年受限制股份单位计划的规则及与受托人订立的信托契约持有。需要注意的是，受托人不能行使其持有股份的表决权。此外，除先前公告中提到的首次授出及进一步授出外，公告日没有另行授出奖励。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2025040909191097329328&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2025040909191097329328&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["AAPG","BK4139"],"gpt_icon":0},{"id":"2526879857","title":"亞盛醫藥4月8日成交額為367.13萬美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2526879857","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2526879857?lang=zh_tw&edition=fundamental","pubTime":"2025-04-09 09:15","pubTimestamp":1744161311,"startTime":"0","endTime":"0","summary":"美东时间2025年4月8日，亚盛医药成交额为367.13万美元，成交额较昨日增加107.97%，当日成交量为18.95万股。亚盛医药于2025年4月8日跌4.61%，报19.46美元，该股过去5个交易日跌15.54%，年初至今涨12.81%，过去60日涨12.81%。它专注于开发抑制蛋白质间相互作用以恢复细胞凋亡或程序性细胞死亡的疗法。该公司的地理部门包括美国和中国大陆。（以上内容为腾讯自选股基于公开消息，由程序或算法智能生成，仅作为用户看盘参考，不作为投资建议或交易依据。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250409091523a4531486&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250409091523a4531486&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["AAPG","BK4139"],"gpt_icon":0}],"pageSize":20,"totalPage":9,"pageCount":7,"totalSize":172,"code":"91000000","status":"200"}]}}